Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study

Blood
Lucía Comellas-KirkerupAntonio R Cabral

Abstract

The updated Sapporo classification criteria for antiphospholipid syndrome (APS) only include thrombosis or pregnancy morbidity as clinical criteria. To test this notion, we studied 55 patients (80% women) with hematologic manifestations. All fulfilled the laboratory criteria for primary APS. Thirty-five patients (64%) had thrombocytopenia, 14 (25%) had autoimmune hemolytic anemia, and 6 (11%) had both. Twenty-five patients (22 women, 88%) also fulfilled one clinical criterion for APS after a median follow-up of 13.2 years (range, 1.45-37 years), whereas the remaining 30 patients (22 women, 73%) have not had any thrombotic event nor pregnancy morbidity after a median follow-up of 5.4 years (range, 0.12-24 years). No patient developed systemic lupus erythematosus during follow-up. The hematologic manifestation was asynchronous with the APS onset in 84% of patients. The response to treatment was similar regardless of the APS status. Patients with definite APS were more frequently positive for the lupus anticoagulant (63%) than lupus anticoagulant-positive patients without APS (30%; odds ratio, 3.5; 95% confidence interval, 1.07-11.4; P < .02). Anticardiolipin or anti-β(2)-glycoprotein-I antibodies were highly prevalent among the s...Continue Reading

References

Apr 1, 1992·Seminars in Arthritis and Rheumatism·D Alarcón-SegoviaJ Cabiedes
Oct 1, 1988·Annals of the Rheumatic Diseases·M A KhamashtaG R Hughes
Jun 1, 1988·The Journal of Experimental Medicine·N OyaizuS Morii
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Aug 1, 1994·Journal of Autoimmunity·B HentatiT Ternynck
Mar 1, 1997·Annals of the Rheumatic Diseases·M J CuadradoG R Hughes
Apr 18, 2008·Blood Reviews·Imad UthmanMunther Khamashta
May 31, 2008·British Journal of Haematology·Carole Pierrot-Deseilligny DespujolBertrand Godeau
Jul 25, 2009·Journal of Thrombosis and Haemostasis : JTH·V PengoUNKNOWN Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the Interna

❮ Previous
Next ❯

Citations

Sep 10, 2010·Current Opinion in Hematology·Sarah Cooley, Daniel S Weisdorf
Sep 19, 2012·Asian Journal of Transfusion Science·Laura ScaramucciPaolo de Fabritiis
Nov 8, 2013·Clinical Rheumatology·Myat Tun Lin Nyo, Asgar Ali Kalla
Mar 30, 2011·Hematology/oncology Clinics of North America·Paula L Bockenstedt
Jun 20, 2014·Journal of Thrombosis and Haemostasis : JTH·M RuggeriUNKNOWN Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Anemia and Thrombocytopenias Working Party. GIMEMA Study ITP0311
Jul 1, 2015·Nature Reviews. Rheumatology·Gerard Espinosa, Ricard Cervera
Mar 6, 2015·Current Rheumatology Reports·Bahar Artim-EsenMurat İnanç
Apr 16, 2015·Case Reports in Pulmonology·Süreyya YilmazCihan Akgul Ozmen
Jan 27, 2015·Current Rheumatology Reports·Giulia PazzolaDoruk Erkan
Oct 23, 2010·Blood·Keith R McCrae
Aug 31, 2016·Internal Medicine Journal·A Y HoiR R C Buchanan
Feb 6, 2017·Medicina clínica·Rosalia Demetrio PabloVictor Manuel Martínez-Taboada
Apr 25, 2012·Hematology·Ricardo Forastiero
Oct 10, 2014·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Sanae Shimamura, Tetsuya Horita
Jun 13, 2020·International Journal of Molecular Sciences·Paul R J AmesFabrizio Gentile
Nov 24, 2019·Blood Reviews·Allyson M PishkoDouglas B Cines

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.